Infections, Rotavirus Clinical Trial
Official title:
A Study to Assess the Impact of Rotavirus Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis (RV GE) in Japan
NCT number | NCT01733862 |
Other study ID # | 116929 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | November 27, 2012 |
Est. completion date | February 8, 2017 |
Verified date | May 2019 |
Source | GlaxoSmithKline |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study aims at assessing the impact of RV vaccination in hospitals in Nagoya City (administrative district), Japan, where RV vaccines have been introduced since November 2011 and financial support for vaccination costs by Nagoya city, Japan have been implemented from October 2012.
Status | Completed |
Enrollment | 5394 |
Est. completion date | February 8, 2017 |
Est. primary completion date | February 8, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 1824 Days |
Eligibility |
Inclusion Criteria: - Children aged less than five years visiting hospitals for RV GE or AGE from 2007 to 2016, who live in the study area. Exclusion Criteria: - Not applicable. |
Country | Name | City | State |
---|---|---|---|
Japan | GSK Investigational Site | Aichi | |
Japan | GSK Investigational Site | Aichi | |
Japan | GSK Investigational Site | Aichi | |
Japan | GSK Investigational Site | Aichi | |
Japan | GSK Investigational Site | Aichi | |
Japan | GSK Investigational Site | Aichi | |
Japan | GSK Investigational Site | Aichi |
Lead Sponsor | Collaborator |
---|---|
GlaxoSmithKline |
Japan,
Yoshikawa T, Matsuki T, Sato K, Mizuno M, Shibata M, Hasegawa S, Morita M, Iwasa M, Gopala K, Holl K. Impact of rotavirus vaccination on the burden of acute gastroenteritis in Nagoya city, Japan. Vaccine. 2018 Jan 25;36(4):527-534. doi: 10.1016/j.vaccine.2017.12.006. Epub 2017 Dec 13. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Occurrence of RV GE hospitalizations among all hospitalized children aged less than five years. | From Nov 2007 to Oct 2016 | ||
Secondary | Occurrence of RV GE hospitalizations among AGE hospitalizations in children less than five years of age. | From Nov 2007 to Oct 2016 | ||
Secondary | Occurrence of RV GE hospitalizations by age group in children less than five years of age. | From Nov 2007 to Oct 2016 | ||
Secondary | Occurrence of AGE hospitalizations among all hospitalized children aged less than five years. | From Nov 2007 to Oct 2016 | ||
Secondary | Occurrence of outpatient visits for AGE among all outpatient visits in children less than five years of age. | From Nov 2007 to Oct 2016 | ||
Secondary | Occurrence of outpatient visits for RV GE among all outpatient visits in children less than five years of age. | From Nov 2007 to Oct 2016 | ||
Secondary | Occurrence of outpatient visits for RV GE among AGE outpatient visits in children less than five years of age. | From Nov 2007 to Oct 2016 | ||
Secondary | Duration of hospitalizations for RV GE or AGE, overall, for each year, season in children less than five years of age. | From Nov 2007 to Oct 2016 | ||
Secondary | Occurrence of hospitalizations for RV GE among all emergency visits for RV GE in children less than five years of age. | From Nov 2007 to Oct 2016 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01435967 -
Observational Study on Rotavirus Gastroenteritis Epidemiology, Impact of Lyophilised vs. Liquid Formulation of Rotarix™
|
N/A | |
Completed |
NCT00370318 -
Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines
|
Phase 3 | |
Completed |
NCT00345956 -
To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam)
|
Phase 3 | |
Completed |
NCT00140686 -
To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines
|
Phase 3 | |
Completed |
NCT00383903 -
Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa
|
Phase 2 | |
Completed |
NCT00750893 -
Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix (Human Rotavirus Vaccine) in Infants
|
||
Completed |
NCT00533507 -
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age
|
Phase 3 | |
Completed |
NCT00363545 -
To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants)
|
Phase 3 | |
Completed |
NCT02914184 -
Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks
|
Phase 3 | |
Completed |
NCT00489567 -
Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden
|
N/A | |
Completed |
NCT00779779 -
Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Infants
|
||
Completed |
NCT00382772 -
A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).
|
Phase 3 | |
Completed |
NCT00729001 -
Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.
|
Phase 2 | |
Completed |
NCT00353366 -
To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination
|
||
Completed |
NCT01198769 -
Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.
|
Phase 4 | |
Completed |
NCT00385320 -
Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months
|
Phase 2 | |
Completed |
NCT00432380 -
A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.
|
Phase 2 | |
Completed |
NCT01563159 -
Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011
|
N/A | |
Completed |
NCT01339221 -
Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in Belgium
|
N/A | |
Completed |
NCT00653198 -
Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama
|
N/A |